Herpes Simplex Type 2 Virus: a new horizon.
Genital herpes or Herpes Simplex Type 2 Virus (HSC-2) is an incurable, venerable disease. Genital herpes infects more than 1 of 5 adolescents and adults according to the Center for Disease Control. Many people do not know that they have it and are not aware that they may be spreading it to others. Treatment and management of herpes simplex virus has been through pharmacotherapy and patient education. Recent studies have emerged identifying a vaccine for herpes simplex virus. The vaccine has thus far proven to be effective for women. Pending further investigation the target population is young adolescent girls. The implications of the vaccine for future treatment and management of other sexually transmitted infections need to be explored.
Tyler
Indira
I
Hampton University School of Nursing, USA. indira.tyler@hamptonu.edu
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000998:Antiviral Agents / Q000627:therapeutic use; D006558:Herpes Genitalis / Q000453:epidemiology / Q000628:therapy* / Q000821:virology; D018258:Herpesvirus 2, Human; D006801:Humans; D010353:Patient Education as Topic; D011159:Population Surveillance; D015995:Prevalence; D014481:United States / Q000453:epidemiology; D047568:Unsafe Sex / Q000706:statistics & numerical data; D014611:Vaccination
D000998:Antiviral Agents